Personalized Antisense Oligonucleotide for a Single Participant With MAPK8IP3 Neurodevelopmental Disorder With or Without Variable Brain Abnormalities (NEDBA)

NCT07197294 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Neurodevelopmental Disorder With or Without Variable Brain Abnormalities

Interventions

DRUG: nL-MAPK8-001

Sponsor

n-Lorem Foundation

Collaborators

[object Object]